1. Home
  2. LXRX vs UMAC Comparison

LXRX vs UMAC Comparison

Compare LXRX & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.47

Market Cap

996.7M

Sector

Health Care

ML Signal

HOLD

Logo Unusual Machines Inc.

UMAC

Unusual Machines Inc.

SELL

Current Price

$17.44

Market Cap

1.1B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
LXRX
UMAC
Founded
1995
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.7M
1.1B
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
LXRX
UMAC
Price
$1.47
$17.44
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$4.47
★ $35.89
AVG Volume (30 Days)
1.9M
★ 2.5M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
77.78
★ 80.73
EPS
N/A
★ 0.06
Revenue
★ $49,803,000.00
$11,199,217.00
Revenue This Year
N/A
$406.76
Revenue Next Year
N/A
$98.42
P/E Ratio
★ N/A
$296.50
Revenue Growth
60.24
★ 101.23
52 Week Low
$1.10
$7.25
52 Week High
$2.68
$34.93

Technical Indicators

Market Signals
Indicator
LXRX
UMAC
Relative Strength Index (RSI) 31.31 39.37
Support Level $1.10 $15.63
Resistance Level $1.81 $20.15
Average True Range (ATR) 0.08 1.35
MACD 0.00 0.03
Stochastic Oscillator 24.69 30.47

Price Performance

Historical Comparison
LXRX
UMAC

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About UMAC Unusual Machines Inc.

Unusual Machines Inc is engaged in manufactures and sells drone components and drones across a diversified brand portfolio through business-to-business (B2B) sales and a curated retail channel.

Share on Social Networks: